US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Sabores Bakery, Dba Sabores A Tu Mesa, Issues Allergy Alert on Undeclared Milk in Mousse Desserts

      Summary Company Announcement Date: June 20, 2025 FDA Publish Date: June … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Recall Of Prescription Cough and Cold Drugs by Neilgen Pharma and Advent Pharmaceutical

Recall Of Prescription Cough and Cold Drugs by Neilgen Pharma and Advent Pharmaceutical

April 22, 2009 By The FDA 1 Comment

CONTACT: BHARAT PATEL, PRESIDENT (609) 448-5500

NEILGEN PHARMA INC. OF WESTMINSTER, MD AND ADVENT PHARMACEUTICAL OF EAST WINDSOR, NJ ARE RECALLING ALL PRESCRIPTION COUGH AND COLD DRUG PRODUCTS SOLD ON OR AFTER MARCH 5, 2008. NEILGEN PHARMA AND ADVENT PHARMACEUTICAL ARE CONTRACT MANUFACTURERS FOR THESE PRODUCTS AND ARE RECALLING THE LISTED PRODUCTS BELOW DUE TO THE UNAPPROVED DRUG PRODUCT CATEGORY.

CONSUMERS TAKING THESE RECALL PRODUCTS WHICH IS BEING RECALLED SHOULDSTOP USING AND RETURN PRODUCT TO PLACE OF PURCHASE AND CONTACT THEIR PHYSICIAN OR HEALTHCARE PROVIDER TO OBTAIN A REPLACEMENT MEDICATION OR PRESCRIPTION.

SAFETY AND EFFECTIVENESS HAVE NOT BEEN ESTABLISHED BY FDA. HOWEVER, PATIENT EXPOSURE TO AFFECTED PRODUCTS IS NOT LIKELY TO CAUSE ADVERSE HEALTH CONSEQUENCES. BOTH NEILGEN PHARMA AND ADVENT PHARMA HAVE STOPPED THE PRODUCTION OF THESE PRODUCTS AND NO INJURIES HAVE BEEN REPORTED TO DATE.

THIS PRECAUTIONARY ACTION IS FOCUSED ON REMOVING PRODUCTS TO THE RETAIL LEVEL ONLY. FDA HAS BEEN APPRISED OF THIS ACTION. ALL OF THE PRODUCTS UNDER RECALL WERE DISTRIBUTED TO WHOLESALERS LOCATED IN ALABAMA AND NORTH CAROLINA.

THE DRUG PRODUCTS CAN BE IDENTIFIED BY PROVIDED NAME, DESCRIPTION AND LOT NUMBERS.

INQUIRIES RELATED TO THIS RECALL SHOULD BE ADDRESSED TO ADVENT PHARMA CUSTOMER SERVICES AT 1-888-634-5522. REPRESENTATIVE IS AVAILABLE MONDAY THROUGH FRIDAY, 8 A.M. TO 5 P.M. EST. ADVERSE REACTIONS OR QUALITY PROBLEMS EXPERIENCED WITH THE USE OF THIS PRODUCT MAY BE REPORTED TO THE FDA’S ADVERSE EVENT REPORTING PROGRAM EITHER ONLINE, BY REGULAR MAIL OR BY FAX.

THIS RECALL INCLUDES ALL LOTS MANUFACTURED/DISTRIBUTED ON OR AFTER MARCH 5, 2008 WITHIN EXPIRATION DATE OF THE PRODUCT LISTED BELOW.

ADVENT PHARMA RECALLED PRODUCTS

NAME

PRODUCT DESCRIPTION

LOT NUMBER

RY-TANN CAPLETS

PHENYLEPHRINE TANNATE 25 MG/ CHLORPHENIRAMINE TANNATE 9 MG CAPLETS

806009, 806010, 806011

D-TANN CT CAPLETS

DIPHENHYDRAMINE TANNATE/PHENYLEPHRINE TANNATE/ CARBETAPENTANE TANNATE  25/10/30 MG  CAPLETS

806003, 806004

NEILGEN PHARMA RECALLED PRODUCTS

NAME

PRODUCT DESCRIPTION

LOT NUMBER

D-TANN SUSPENSION

DIPHENHYDRAMINE TANNATE/PHENYLEPHRINE TANNATE 25/7.5 MG SUSPENSION

L08C192, L08D171, L08E121, L08E131,

D-TANN CT SUSPENSION

DIPHENHYDRAMINE TANNATE/PHENYLEPHRINE TANNATE/ CARBETAPENTANE TANNATE 25/10/30 MG  SUSPENSION

L08C201, L08E071, L08E091

BEN-TANN SUSPENSION

DIPHENHYDRAMINE TANNATE 25 MG SUSPENSION

L08D032, L08E061

D-TANN AT SUSPENSION

DIPHENHYDRAMINE TANNATE/ CARBETAPENTANE TANNATE 25/30 MG SUSPENSION

L08E271, L08E281

D-TANN CD SUSPENSION

DIPHENHYDRAMINE TANNATE/ PHENYLEPHRINE TANNATE/ CARBETAPENTANE TANNATE 25/15/30 MG SUSPENSION

L08F051

D-TANN DM SUSPENSION

DIPHENHYDRAMINE TANNATE/ PHENYLEPHRINE TANNATE/ DEXTROMETHORPHAN TANNATE 25/7.5/75 MG SUSPENSION

L08F121, L08F131

B-VEX SUSPENSION

BROMPHENIRAMINE TANNATE 12 MG SUSPENSION

L08D031, L08E021, L08E051

B-VEX D SUSPENSION

BROMPHENIRAMINE TANNATE/ PHENYLEPHRINE TANNATE 12/20 MG SUSPENSION

L08D031, L08D181

BROM TANN 8 MG/DM TANN 60 MG/PSE TANN 90 MG SUSPENSION

BROMPHENIRAMINE TANNATE/ DEXTROMETHORPHAN TANNATE/ PSEUDOEPHEDRINE TANNATE 8/60/90 MG SUSPENSION

L08C181, L08D041

DM TANN 30 MG/ PE TANN/25 MG BROM TANN 10 MG SUSPENSION

DEXTROMETHORPHAN TANNATE/ PHENYLEPHRINE TANNATE/ BROMPHENIRAMINE TANNATE 30/25/10 MG SUSPENSION

L08D091, L08D223 L08E161, L08F111

 PE TANN 20 MG/ CP TANN 4 MG SUSPENSION

PHENYLEPHRINE TANNATE/ CHLORPHENIRAMINE TANNATE 20/4 MG SUSPENSION

L08D222, L08E201 L08F102

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Comments

  1. steven says

    June 20, 2009 at 7:37 am

    is oxycodone illegal yet with a script ? justs wondered ..because im taking it from steve in southern ca

    Reply

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Sabores Bakery, Dba Sabores A Tu Mesa, Issues Allergy Alert on Undeclared Milk in Mousse Desserts

June 20, 2025 By The FDA

Face Rock Creamery Voluntarily Recalls Vampire Slayer Garlic Cheddar Curds Because of Possible Health Risk

June 20, 2025 By The FDA

International Foodsource, LLC. Issues Allergy Alert in Nonpareil, Semi-Sweet Chocolate (Christmas Seeds) Sold as Dark Chocolate Nonpareils

June 20, 2025 By The FDA

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

AstroAI Recalls Minifridges Due to Fire and Burn Hazards; Two Fires Resulted in More Than $360,000 in Reported Property Damages

June 17, 2025 By The CPSC

Polaris Recalls Ranger XP Kinetic and Pro XD Kinetic Recreational Off-Highway Vehicles (ROVs) Due to Fire Hazard

June 17, 2025 By The CPSC

Crayan Mattresses Recalled Due to Risk of Serious Injury or Death from Fire Hazard; Violation of Federal Standard for Mattress Flammability; Sold Exclusively on Amazon by Crayan

June 17, 2025 By The CPSC

TADAKAZU Baby Loungers Recalled Due to Risk of Serious Injury or Death from Suffocation, Fall and Entrapment Hazards; Violations of Federal Standard for Infant Sleep Products; Sold on Amazon

June 17, 2025 By The CPSC

MaxKare Electric Blankets Recalled Due to Burn and Fire Hazards; Manufactured by Yumo and Sold Exclusively on Walmart.com

June 17, 2025 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

TADAKAZU Baby Loungers Recalled Due to Risk of Serious Injury or Death from Suffocation, Fall and Entrapment Hazards; Violations of Federal Standard for Infant Sleep Products; Sold on Amazon

June 17, 2025 By The CPSC

MaxKare Electric Blankets Recalled Due to Burn and Fire Hazards; Manufactured by Yumo and Sold Exclusively on Walmart.com

June 17, 2025 By The CPSC

Weaver Nut Company Inc., Issues Allergy Alert on Undeclared Milk in Chocolate Nonpareils

June 17, 2025 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Sabores Bakery, Dba Sabores A Tu Mesa, Issues Allergy Alert on Undeclared Milk in Mousse Desserts
  • Face Rock Creamery Voluntarily Recalls Vampire Slayer Garlic Cheddar Curds Because of Possible Health Risk
  • International Foodsource, LLC. Issues Allergy Alert in Nonpareil, Semi-Sweet Chocolate (Christmas Seeds) Sold as Dark Chocolate Nonpareils
  • Lipari Foods Issues Allergy Alert on Undeclared Milk in “Dark Chocolate Nonpareils”
  • YaFiti White Dressers Recalled Due to Risk of Serious Injury or Death from Tip-Over and Entrapment Hazards; Violations of Federal Standard for Clothing Storage Units; Sold on Amazon
  • AstroAI Recalls Minifridges Due to Fire and Burn Hazards; Two Fires Resulted in More Than $360,000 in Reported Property Damages
  • Polaris Recalls Ranger XP Kinetic and Pro XD Kinetic Recreational Off-Highway Vehicles (ROVs) Due to Fire Hazard
  • Crayan Mattresses Recalled Due to Risk of Serious Injury or Death from Fire Hazard; Violation of Federal Standard for Mattress Flammability; Sold Exclusively on Amazon by Crayan
  • TADAKAZU Baby Loungers Recalled Due to Risk of Serious Injury or Death from Suffocation, Fall and Entrapment Hazards; Violations of Federal Standard for Infant Sleep Products; Sold on Amazon
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2025 Altrumedia · Terms of Service · Log in